2011 IPO
Fluidigm Stock
Microfluidic based chips
Sign up today and learn more about Fluidigm Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Fluidigm Stock
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.
Funding History
| November 2001 | $34.0M |
|---|---|
| January 2004 | $21.0M |
| September 2005 | $10.0M |
| January 2007 | $37.0M |
| September 2009 | $10.7M |
| November 2009 | $7.5M |
| January 2011 | $5.0M |
Management
EVP , Research & Development
Robert C. Jones
VP , European Commercial Operations and General Manager of Fluidigm Europe BV
Dominique Remy-Renou
EVP , Executive Vice President, General Counsel, Legal Affairs
William M. Smith
Sr. Director R&D Engineering
Kyle Hukari
COO
Fred Walder
President, CEO, and Co-Founder
Gajus Worthington
CFO
Vikram Jog
General Manager, Production Genomics
Steven C. McPhail
EVP , Worldwide ManufacturingFluidigm Singapore
Grace Yow
EquityZen Recognized As:
